Published by The nationwide recall involves Nara Organics Whole Milk Infant Formula sold in 700g and 400g cans through Target retail stores, Target.com, and Nara.com between July 2025 and June 2026. Nara stated that the recall was issued out of an abundance of caution because of the potential risk of Clostridium botulinum contamination.
The FDA-posted recall says the three infants were hospitalized in California, Washington, and Pennsylvania and treated with BabyBIG, Botulism Immune Globulin Intravenous. No deaths had been reported at the time of the recall.
Families whose infants consumed recalled Nara formula and developed botulism symptoms, required hospitalization, or needed emergency medical care may want to preserve cans, lot codes, purchase records, medical records, and refund communications for a legal evaluation.
Quick Facts
- Nara Organics recalled all lots of Nara Whole Milk Powdered Infant Formula currently on the market.
- The recall was announced on June 13, 2026, due to a potential risk of Clostridium botulinum contamination.
- FDA and CDC reported three infant botulism cases in babies who had consumed Nara formula.
- The affected formula was sold nationally through Target stores, Target.com, and Nara.com.
Table Of Contents
- Latest News & Updates on Nara Infant Formula Recall Lawsuits
- What Is Nara Infant Formula?
- Reported Risks or Injuries
- How Does the Problem Occur, and Who May Be Liable?
- Who May Be Affected?
- Do I Qualify?
- Do I Have a Nara Infant Formula Recall Lawsuit?
- Important Legal Actions or Recalls
- Potential Compensation
- Legal Process Overview
- Frequently Asked Questions About Nara Infant Formula Recall Lawsuits
- What is the Nara Infant Formula Recall Lawsuit Evaluation about?
- Which Nara infant formula products were recalled?
- Why was Nara infant formula recalled?
- What symptoms may be linked to infant botulism?
- Who may qualify for a Nara Infant Formula Recall Lawsuit?
- Has Nara formula tested positive for Clostridium botulinum?
- What should parents do with recalled Nara formula?
- What evidence should I save for a Nara Infant Formula Recall Lawsuit?
- References
Latest News & Updates on Nara Infant Formula Recall Lawsuits
June 2026
Nara Organics announced a voluntary recall of all lots of Nara Organics Powdered Infant Formula currently on the market after FDA and CDC officials contacted the company about three infant botulism cases in babies who had consumed Nara formula. The recalled products include Nara Organics Whole Milk Infant Formula in 700g cans with UPC 860013251901 and 400g cans with UPC 860013251918 [1].
CDC describes botulism as a rare but serious illness caused by a toxin that attacks the body’s nerves and can lead to difficulty breathing, muscle paralysis, and death. CDC also explains that infant botulism can occur when spores enter an infant’s intestines, grow, and produce toxin [2].
FDA’s infant formula materials explain that formulas sold in the United States must meet federal nutrient and safety requirements, and manufacturers must follow sanitary controls intended to prevent contamination during manufacturing. Those safeguards are especially important because infant formula may be a baby’s sole source of nutrition [3].
What Is Nara Infant Formula?
Nara Infant Formula is a powdered whole milk infant formula sold under the Nara Organics brand. The recalled products were distributed nationally in the United States through Target retail stores, Target.com, and Nara.com.
The recall covers:
- Nara Organics Whole Milk Infant Formula, 700g, UPC 860013251901
- Nara Organics Whole Milk Infant Formula, 400g, UPC 860013251918
All lots currently on the market are included in the recall. The lot code can be found on the bottom of each can.
The three lots reportedly consumed by the hospitalized infants were 709125280E14F2, 709125288E14F2, and 708125174E14F2. Nara stated that, to date, Nara infant formula had not tested positive for C. botulinum, but the company recalled all products currently in market while working with FDA, CDC, and state partners.
For families, the bottom-of-can lot code may be critical. Photos of the can, UPC, lot code, purchase source, refund submission, and any remaining formula can help show whether the product matches the recall and whether it may be connected to a child’s illness timeline.
Reported Risks or Injuries
The reported risk is infant botulism, a rare but potentially fatal illness that can occur when Clostridium botulinum spores are ingested, colonize an infant’s intestinal tract, and produce botulinum neurotoxins.
The FDA-posted recall lists possible symptoms including constipation, poor feeding, drooping eyelid, sluggish pupils, low muscle tone, difficulty sucking and swallowing, weak or altered cry, generalized weakness, respiratory difficulty, and possible respiratory arrest.
Nara’s recall also instructed parents to contact a healthcare provider for immediate care if a baby who consumed the product develops symptoms such as vomiting, diarrhea, constipation, poor feeding, drooping eyelids, or weak crying.
Infant botulism cases can become medical emergencies because the illness may affect breathing, feeding, muscle tone, and neurological function. In the reported Nara cases, all three infants were hospitalized and treated with BabyBIG.
How Does the Problem Occur, and Who May Be Liable?
The suspected problem involves possible exposure to Clostridium botulinum spores through recalled powdered infant formula. If spores are ingested by an infant, they may colonize the immature gut and produce toxin.
In a legal investigation, attorneys may examine manufacturing records, sanitation controls, ingredient sourcing, environmental testing, finished-product testing, distribution records, complaint history, recall timing, and communications with regulators. The investigation may also consider whether the company acted reasonably once public health officials identified possible cases connected to the formula.
Potentially liable parties may include the manufacturer, distributor, retailer, online seller, supplier, or other entities involved in the product chain. Liability depends on proof of exposure, product identification, medical evidence, causation, damages, and applicable law.
These cases may turn on details that parents do not have access to, such as plant conditions, testing records, retained samples, and traceback information. That makes preserving consumer-level evidence—cans, lot codes, receipts, photographs, and medical records—especially important at the beginning of a claim.
Who May Be Affected?
Families who purchased Nara Organics Whole Milk Infant Formula from Target stores, Target.com, or Nara.com between July 2025 and June 2026 may be affected. The formula was distributed nationally and was not distributed outside the United States.
Infants who consumed recalled formula and later developed symptoms consistent with infant botulism may be especially relevant for a legal evaluation. Parents should seek immediate medical care for concerning symptoms rather than waiting to see whether they improve.
Families may also be affected if they still have unopened or partially used cans from the recalled lots. Unused product, photos of lot codes, and purchase records can help with both recall refunds and potential legal review.
Do I Qualify?
You may qualify for a legal review if your baby consumed recalled Nara infant formula and developed infant botulism symptoms, required hospitalization, received BabyBIG treatment, or needed emergency medical evaluation. The review will likely focus on product identification, medical records, timing, and whether the illness is consistent with the recall concern.
Helpful evidence may include:
- Nara formula cans, lids, lot codes, UPCs, and photos of the bottom of each can
- Target receipts, Target.com records, Nara.com order records, credit card records, or delivery confirmations
- Medical records, hospital records, pediatrician notes, lab results, discharge summaries, and BabyBIG treatment records
- A written timeline showing when the formula was purchased, opened, fed, and when symptoms began
- Refund submissions, recall emails, communications with Nara, Target, FDA, CDC, or state health officials
Parents should not rely on memory alone when reconstructing feeding history. Formula can rotation, partial cans, daycare use, travel, and mixed feeding schedules can make written documentation more important.
Do I Have a Nara Infant Formula Recall Lawsuit?
If you or a loved one has been injured by Nara infant formula, you may have legal options. Contact Schmidt & Clark for a free case review.
Important Legal Actions or Recalls
| Event | Month/Year | Type | Status | Notes | Source |
|---|---|---|---|---|---|
| Nara infant formula recall announced | June 2026 | FDA-posted company recall | Active | Nara recalled all lots of Nara Organics Powdered Infant Formula currently on the market | FDA |
| Potential botulism risk identified | June 2026 | Food safety concern | Under investigation | Recall was issued because of possible Clostridium botulinum contamination | FDA |
| Three infant botulism cases reported | June 2026 | Illness reports | Reported | Three infants in California, Washington, and Pennsylvania were hospitalized and treated with BabyBIG | FDA |
| Refund process announced | June 2026 | Consumer remedy | Available | Nara announced automatic refunds for certain Nara.com purchases and refund options for other customers with unused product | FDA |
Potential Compensation
Potential compensation in a Nara infant formula claim may include emergency care, hospitalization, intensive monitoring, BabyBIG treatment, physician visits, lab testing, follow-up care, and other medical expenses. Families may also seek reimbursement for related out-of-pocket costs.
In more serious cases, damages may include pain and suffering, long-term complications, developmental monitoring, emotional distress, lost wages for parents, travel expenses, and future medical needs. The value of a claim depends on the child’s diagnosis, severity of illness, medical records, product proof, and applicable law.
Compensation amounts vary by case. Past results do not guarantee future outcomes.
Legal Process Overview
Free case review: The process begins with a confidential review of the formula purchase history, lot codes, feeding timeline, symptoms, and medical care. Families may be asked for photos of cans, receipts, refund records, and hospital documents.
Evidence preservation: Parents should preserve cans, lot codes, UPCs, photos, remaining formula, purchase records, and medical documentation where possible. If a refund process requires product photos, take clear images before returning or discarding anything.
Investigation: Attorneys may evaluate whether the product matches the recall, whether the infant’s symptoms align with botulism, and whether medical records support the illness connection. Public health updates, FDA materials, distribution records, and company communications may also be reviewed.
Filing: If the evidence supports a claim, a lawsuit may allege product defect, negligence, failure to warn, breach of warranty, or other claims depending on state law. Filing deadlines vary, so early review can help protect potential rights.
Resolution: A case may resolve through settlement, dismissal, court ruling, or trial. The timeline depends on medical complexity, product evidence, public health findings, available defendants, and how the responsible parties respond.
Frequently Asked Questions About Nara Infant Formula Recall Lawsuits
What is the Nara Infant Formula Recall Lawsuit Evaluation about?
The Nara Infant Formula Recall Lawsuit Evaluation concerns potential claims by families whose babies consumed recalled Nara formula and later developed infant botulism symptoms or required medical care. The recall involves all lots of Nara Organics Powdered Infant Formula currently on the market.
Which Nara infant formula products were recalled?
The recall includes Nara Organics Whole Milk Infant Formula in 700g cans with UPC 860013251901 and 400g cans with UPC 860013251918. All lots currently on the market are included.
Why was Nara infant formula recalled?
Nara recalled the formula because of a potential risk of Clostridium botulinum contamination. FDA and CDC reported three infant botulism cases in babies who had consumed Nara formula.
What symptoms may be linked to infant botulism?
Possible symptoms include constipation, poor feeding, drooping eyelids, sluggish pupils, low muscle tone, difficulty sucking and swallowing, weak or altered cry, generalized weakness, respiratory difficulty, and possible respiratory arrest. Parents should seek immediate medical care if a baby develops concerning symptoms after consuming recalled formula.
Who may qualify for a Nara Infant Formula Recall Lawsuit?
A family may qualify for a Nara Infant Formula Recall Lawsuit review if an infant consumed recalled Nara formula and developed botulism symptoms, required hospitalization, or received treatment such as BabyBIG. Product proof and medical records can help support the evaluation.
Has Nara formula tested positive for Clostridium botulinum?
The FDA-posted recall states that, to date, Nara infant formula had not tested positive for C. botulinum. Nara still recalled all products currently in market while working with FDA, CDC, and state partners.
What should parents do with recalled Nara formula?
Customers should stop using the recalled products immediately. Parents should photograph the can, UPC, lot code, and bottom of the container before requesting a refund or returning the product.
What evidence should I save for a Nara Infant Formula Recall Lawsuit?
Save formula cans, lot codes, purchase records, refund communications, feeding logs, symptom timelines, hospital records, pediatrician notes, lab results, and BabyBIG treatment records. These documents may help connect product use, timing, illness, and damages.
References
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/nara-organics-recalls-all-lots-nara-infant-formula-because-possible-health-risk
- https://www.cdc.gov/botulism/about/index.html
- https://www.fda.gov/food/resources-you-food/infant-formula-homepage